SCHEMBL9049040

SCHEMBL9049040

CS(=O)(=O)c1ccc(-n2nc(-c3cccc(C(=O)O)c3)cc2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.67
RARA P10276 5/20 0.65
RARB P10826 5/20 0.65
RARG P13631 5/20 0.65
RXRA P19793 5/20 0.65
ALOX5 P09917 1/20 0.54
PTGS1 P23219 1/20 0.53
RPA1 P27694 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CYP2C9 P11712 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9038810 0.97 RARG (0.69) PTGS2RARARARBRARGRXRA
SCHEMBL9038988 0.90 PTGS2 (0.74) PTGS2RARARARBRARGRXRA
SCHEMBL9038078 0.90 PTGS2 (0.74) PTGS2RARARARBRARGRXRA
SCHEMBL8119257 0.90 PTGS2 (0.67) PTGS2PTGS1SMN1; SMN2CYP2C9
SCHEMBL8423407 0.88 PTGS2 (0.73) PTGS2RARARARBRARGRXRA
SCHEMBL8421185 0.88 PTGS2 (0.80) PTGS2RARARARBRARGRXRA
SCHEMBL8420828 0.88 PTGS2 (0.80) PTGS2RARARARBRARGRXRA
SCHEMBL8424552 0.87 PTGS2 (0.69) PTGS2RARARARBRARGRXRA
SCHEMBL8120201 0.87 PTGS2 (0.66) PTGS2RARARARBRARGRXRA
SCHEMBL8422291 0.86 PTGS2 (0.62) PTGS2RARARARBRARGRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731796-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-09-18 EP disclosed
US-5434178-A 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation G.D. SEARLE & CO. (US) 1995-07-18 US disclosed
WO-1995015318-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed